Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Goldman Sachs
New York City, New York, United Statesgoldmansachs.com ↗
- Ownership
- Private
- Employees
- ~45000
- Development stage
- Other
01
Overview
Goldman Sachs has launched its first dedicated life sciences venture fund—West Street Life Sciences I—with $650 million raised to invest primarily in early and mid-stage therapeutic and diagnostics/tool companies. The fund focuses on precision medicine, genetic medicine, cell therapy, immunotherapy, synthetic biology and artificial intelligence within the healthcare sector. About $90 million has already been invested across five portfolio biotechs including Moma Therapeutics and Nested Therapeutics
- Modalities
- Small moleculeMonoclonal antibodyCell therapyGene therapyImmunotherapySynthetic biology
- Industry
- Investors
Beyond the preview
Go deeper on Goldman Sachs.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Goldman Sachs.